MedPath

chloral hydrate, combination of chloral hydrate - promethazine and combination of chloral hydrate - hydroxyzine in sedation induction for electroencephalography of childre

Not Applicable
Conditions
epilepsy.
Epilepsy and paroxysmal disorders
G40, G47
Registration Number
IRCT201204262639N8
Lead Sponsor
Ali-ebn-Abitaleb School of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

1.Children who are referred to EEG center but don’t obey,
2.Age 1-7 years old
3.Class 1 or 2 of ASA
Exclusion criteria:
1.Presence of gastritis or any other serious systemic diseases
2.Severe systemic reaction
3.History of allergy to drug
4.The patient does not use the drug completely

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success in recording of EEG. Timepoint: every 15 minutes. Method of measurement: clinical exam.;Adequate sedation (Ramsay score of four is attained). Timepoint: every 15 minutes. Method of measurement: clinical exam.
Secondary Outcome Measures
NameTimeMethod
Total stay time in EEG unit. Timepoint: every 30 minutes. Method of measurement: asking from parents.;Side effects. Timepoint: every 15 minutes. Method of measurement: clinical exam.;Time to induction of adequate sedation. Timepoint: every 15 minutes. Method of measurement: clinical exam.;Caregiver’s satisfaction. Timepoint: after one hour of drug use. Method of measurement: asking from caregiver.
© Copyright 2025. All Rights Reserved by MedPath